Showing results (861-870 of 2,282) with videos related to
Sort By:
Pageof 229
HIV Medicine|September 15, 2005
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral loadJ A Arranz Caso, J C López, I Santos, et al.HIV Medicine|September 15, 2005
Clinical benefit of interventions driven by therapeutic drug monitoringAl Rendón, M Núñez, I Jiménez-Nácher, et al.HIV Medicine|September 15, 2005
Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic settingC K Fairley, A Permana, T R H ReadHIV Medicine|April 6, 2005
There and back again: the impact of adult HIV prevalence on national life expectanciesA L McGuire, J M Barer, J S G Montaner, et al.HIV Medicine|April 6, 2005
Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?J Bäuerle, M Laguno, S Mauss, et al.HIV Medicine|July 14, 2005
Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxisP T Cantey, D S Stephens, D RimlandHIV Medicine|July 14, 2005
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?I Perbost, B Malafronte, C Pradier, et al.HIV Medicine|May 7, 2005
Gender difference in HIV-1 RNA viral loadsC A Donnelly, L M Bartley, A C Ghani, et al.HIV Medicine|May 7, 2005
Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsulesS D Portsmouth, J Osorio, K McCormick, et al.HIV Medicine|May 7, 2005
Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south LondonA H Mohsen, S Murad, P J EasterbrookPageof 229